Activation of p38 signaling increases utrophin A expression in skeletal muscle via the RNA-binding protein KSRP and inhibition of AU-rich element-mediated mRNA decay: implications for novel DMD therapeutics
Open Access
- 10 April 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 22 (15) , 3093-3111
Abstract
Several therapeutic approaches are currently being developed for Duchenne muscular dystrophy (DMD) including upregulating the levels of endogenous utrophin A in dystrophic fibers. Here, we examined the role of post-transcriptional mechanisms in controlling utrophin A expression in skeletal muscle. We show that activation of p38 leads to an increase in utrophin A independently of a transcriptional induction. Rather, p38 controls the levels of utrophin A mRNA by extending the half-life of transcripts via AU-rich elements (AREs). This mechanism critically depends on a decrease in the functional availability of KSRP, an RNA-binding protein known to promote decay of ARE-containing transcripts. In vitro and in vivo binding studies revealed that KSRP interacts with specific AREs located within the utrophin A 3′ UTR. Electroporation experiments to knockdown KSRP led to an increase in utrophin A in wild-type and mdx mouse muscles. In pre-clinical studies, treatment of mdx mice with heparin, an activator of p38, causes a pronounced increase in utrophin A in diaphragm muscle fibers. Together, these studies identify a pathway that culminates in the post-transcriptional regulation of utrophin A through increases in mRNA stability. Furthermore, our results constitute proof-of-principle showing that pharmacological activation of p38 may prove beneficial as a novel therapeutic approach for DMD.Keywords
This publication has 104 references indexed in Scilit:
- Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1β via a noncanonical caspase-8 inflammasomeNature Immunology, 2012
- RNA-binding proteins and gene regulation in myogenesisTrends in Pharmacological Sciences, 2011
- PI3K/AKT signaling determines a dynamic switch between distinct KSRP functions favoring skeletal myogenesisCell Death & Differentiation, 2011
- Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx miceProceedings of the National Academy of Sciences, 2010
- TNF/p38α/Polycomb Signaling to Pax7 Locus in Satellite Cells Links Inflammation to the Epigenetic Control of Muscle RegenerationCell Stem Cell, 2010
- The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAsNature, 2009
- Phosphorylation-mediated unfolding of a KH domain regulates KSRP localization via 14-3-3 bindingNature Structural & Molecular Biology, 2009
- Functional Interdependence at the Chromatin Level between the MKK6/p38 and IGF1/PI3K/AKT Pathways during Muscle DifferentiationMolecular Cell, 2007
- Viral-mediated gene therapy for the muscular dystrophies: Successes, limitations and recent advancesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2007
- Diagnosis and cell-based therapy for Duchenne muscular dystrophy in humans, mice, and zebrafishJournal of Human Genetics, 2006